UKBizDB.co.uk

IHEALTH PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Ihealth Pharma Limited. The company was founded 5 years ago and was given the registration number 11867659. The firm's registered office is in LONDON. You can find them at 71-75 Shelton Street, , London, Greater London. This company's SIC code is 46460 - Wholesale of pharmaceutical goods.

Company Information

Name:IHEALTH PHARMA LIMITED
Company Number:11867659
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:07 March 2019
End of financial year:31 December 2022
Jurisdiction:England - Wales
Industry Codes:
  • 46460 - Wholesale of pharmaceutical goods
  • 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.

Office Address & Contact

Registered Address:71-75 Shelton Street, London, Greater London, United Kingdom, WC2H 9JQ
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
12, Lime Road, Oxford, England, OX2 9EG

Director01 September 2023Active
19, Mayis Mah Caddesi, Sisli Plaza Sitesi, No: 7/1-85 Sisli, Istanbul, Turkey,

Director07 March 2019Active

People with Significant Control

Murat Ozen
Notified on:07 March 2019
Status:Active
Date of birth:December 1966
Nationality:Turkish
Country of residence:Turkey
Address:19, Mayis Mah Caddesi, Sisli Plaza Sitesi, Istanbul, Turkey,
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.